Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Meyer-Lindenberg, Andreas
Dickson, Suzanne L.
Millan, Mark J.
and
Knudsen, Gitte M.
2022.
Prospects for improved prevention and treatment of neuropsychiatric disorders: Neuroscience Applied.
Neuroscience Applied,
Vol. 1,
Issue. ,
p.
100103.
Smausz, Rebecca
Neill, Joanna
and
Gigg, John
2022.
Neural mechanisms underlying psilocybin’s therapeutic potential – the need for preclinical in vivo electrophysiology.
Journal of Psychopharmacology,
Vol. 36,
Issue. 7,
p.
781.
Brandwein, Christiane
Leenaars, Cathalijn H.C.
Becker, Laura
Pfeiffer, Natascha
Iorgu, Ana-Maria
Hahn, Melissa
Vairani, Gaia A.
Lewejohann, Lars
Bleich, André
Mallien, Anne S.
and
Gass, Peter
2023.
A systematic mapping review of the evolution of the rat Forced Swim Test: Protocols and outcome parameters.
Pharmacological Research,
Vol. 196,
Issue. ,
p.
106917.
Zhang, Jing-Yi
Wang, Ya-Tao
Sun, Lu
Wang, Sai-Qi
and
Chen, Zhe-Sheng
2023.
Synthesis and clinical application of new drugs approved by FDA in 2022.
Molecular Biomedicine,
Vol. 4,
Issue. 1,
Oliveira-Maia, Albino J.
Rive, Benoit
Morrens, Joachim
Godinov, Yordan
Cabrieto, Jedelyn
Perualila, Nolen
and
Mulhern-Haughey, Siobhán
2023.
Indirect adjusted comparison of 6-month clinical outcomes between esketamine nasal spray and other real-world polypharmacy treatment strategies for treatment resistant depression: results from the ICEBERG study.
Frontiers in Psychiatry,
Vol. 14,
Issue. ,
Di Bartolomeo, Luca
Custurone, Paolo
Irrera, Natasha
Borgia, Francesco
Vaccaro, Federico
Squadrito, Francesco
and
Vaccaro, Mario
2023.
Vitiligo and Mental Health: Natural Compounds’ Usefulness.
Antioxidants,
Vol. 12,
Issue. 1,
p.
176.
Pan, Jin
Lu, Yanting
Wang, Sijia
Ma, Ting
Xue, Xiaoyan
Zhang, Zhe
Mao, Qiancheng
Guo, Dongjing
and
Ma, Ke
2023.
Synergistic neuroprotective effects of two natural medicinal plants against CORT-induced nerve cell injury by correcting neurotransmitter deficits and inflammation imbalance.
Phytomedicine,
Vol. 121,
Issue. ,
p.
155102.
Kositsyn, Yuriy M.
de Abreu, Murilo S.
Kolesnikova, Tatiana O.
Lagunin, Alexey A.
Poroikov, Vladimir V.
Harutyunyan, Hasmik S.
Yenkoyan, Konstantin B.
and
Kalueff, Allan V.
2023.
Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies.
International Journal of Molecular Sciences,
Vol. 24,
Issue. 11,
p.
9482.
Serretti, Alessandro
2023.
Innovation in psychopharmacology.
International Clinical Psychopharmacology,
Vol. 38,
Issue. 5,
p.
281.
Sedway, Jan A.
Opler, Mark G. A.
and
Citrome, Leslie
2024.
Antidepressant medications have evolved in terms of speed of onset of efficacy: How can we best measure antidepressant treatment response?.
Current Medical Research and Opinion,
Vol. 40,
Issue. 4,
p.
701.
Iqbal, Syed Z.
Saxena, Kirti
Lateef, Amir
Khan, Samiyah
Blassingame, Jonathan
and
Shah, Asim A.
2024.
Treatment-Resistant Depression and Medications.
Psychiatric Annals,
Vol. 54,
Issue. 6,
Duan, Wenwen
Cao, Dongmei
Wang, Sheng
and
Cheng, Jianjun
2024.
Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants.
Chemical Reviews,
Vol. 124,
Issue. 1,
p.
124.
Gonda, Xenia
Tarazi, Frank I.
and
Dome, Peter
2024.
The emergence of antidepressant drugs targeting GABAA receptors: A concise review.
Biochemical Pharmacology,
Vol. 228,
Issue. ,
p.
116481.
Gong, Guowei
Ganesan, Kumar
Wang, Yongjie
Zhang, Zhenxia
Liu, Yaqun
Wang, Junli
Yang, Fenglian
and
Zheng, Yuzhong
2024.
Ononin ameliorates depression-like behaviors by regulating BDNF-TrkB-CREB signaling in vitro and in vivo.
Journal of Ethnopharmacology,
Vol. 320,
Issue. ,
p.
117375.
Greydanus, Donald E.
Nazeer, Ahsan
Qayyum, Zheala
Patel, Dilip R.
Rausch, Rebecca
Hoang, Linh-Nhu
Miller, Caroline
Chahin, Summer
Apple, Roger W.
Saha, Gautam
Prasad Rao, G.
and
Javed, Afzal
2024.
Pediatric suicide: Review of a preventable tragedy.
Disease-a-Month,
Vol. 70,
Issue. 9,
p.
101725.
Olivier, Berend
and
Olivier, Jocelien D. A.
2024.
Recent Advances and Challenges in the Treatment of Major Depressive Disorder.
Vol. 1456,
Issue. ,
p.
49.
Kurkin, D.V.
Morkovin, E.I.
Bakulin, D.A.
Gorbunova, Yu.V.
Ivanova, O.V.
Pavlova, E.V.
Zvereva, V.I.
Dzhavakhyan, M.A.
Krysanov, I.S.
Kolosov, Yu.A.
Zaborovsky, A.V.
Strygin, A.V.
Petrov, V.I.
Beliy, P.A.
Zaslavskaya, K.Y.
Maltsev, D.V.
and
Skripka, M.O.
2024.
Targeting NMDAR/AMPAR: a promising pharmacotherapeutic approach for depressive disorders.
S.S. Korsakov Journal of Neurology and Psychiatry,
Vol. 124,
Issue. 5,
p.
22.
Nicosia, Noemi
Giovenzana, Mattia
Misztak, Paulina
Mingardi, Jessica
and
Musazzi, Laura
2024.
Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders.
International Journal of Molecular Sciences,
Vol. 25,
Issue. 12,
p.
6521.
Shi, Mingqin
Li, Zhenmin
Tang, Zhengxiu
Zhou, Haimei
Huang, Xiaoyi
Wei, Yuanyuan
Li, Xinyao
Li, Xiahuang
Shi, Hongling
and
Qin, Dongdong
2024.
Exploring the pathogenesis and treatment of PSD from the perspective of gut microbiota.
Brain Research Bulletin,
Vol. 215,
Issue. ,
p.
111022.
Sharma, Aditya
Alam, Md. Aftab
Kaur, Awaneet
Sharma, Shaweta
and
Yadav, Shikha
2024.
Psychopharmacological Treatment of Depression and Anxiety and
their Different Drug Delivery Targets.
Current Psychiatry Research and Reviews,
Vol. 20,
Issue. 4,
p.
297.